Adicet Bio

Adicet is a biotechnology company engaged in the development of first-in-class off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet has developed a proprietary cell platform process to activate, engineer and expand gamma delta T cells. The process allows for generation of cell banks that can be used to treat many patients.